Skip to main content

FDA Approvals

FDA Approvals, In the News
FDA Approves Split-Dosing Regimen for Daratumumab in Patients with Multiple Myeloma
Read More
FDA Approvals, In the News
February 1, 2019 - FDA Approvals, News & Updates
Read More
FDA Approvals, In the News
Government Shutdown Impacts FDA Drug Approvals
Read More
FDA Approvals
A “Gold Standard” for Population Health? Revisiting the FDA’s Relationship with the Hippocratic Oath
Gillian Woollett, MA, DPhil , Bruce S. Pyenson, FSA, MAAA
Read More
FDA Approvals
First FDA-Approved Test to Help Detect Several Leukemias and Lymphomas
Read More
FDA Approvals
First CAR T-Cell Therapy Unanimously Recommended by FDA Advisory Committee for Treatment of B-Cell ALL in Children and Young Adults
Read More
FDA Approvals, In the News
Rituximab Combination Now Approved in 3 Blood Cancers
Read More
FDA Approvals
Darzalex Combined with Pomalidomide and Dexamethasone Approved for Relapsed/Refractory Multiple Myeloma
Read More
FDA Approvals
Keytruda First Cancer Drug Approved for Any Solid Tumor Based on a Biomarker Instead of Tumor Site
Read More
FDA Approvals
Imfinzi a New PD-L1 Approved for Bladder Cancer After Platinum-Based Chemotherapy
Read More
Page 15 of 20
Results 141 - 150 of 200